[The treatment of inflammatory liver diseases with 6-mercaptopurine (6-MP)].
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D002908:Chronic Disease; D004912:Erythrocytes; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D007501:Iron / Q000097:blood; D007962:Leukocytes; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged
D001798:Blood Proteins; D006454:Hemoglobins; D007501:Iron; D015122:Mercaptopurine; D000469:Alkaline Phosphatase; D001663:Bilirubin
Die Behandlung entzündlicher Lebererkrankungen mit 6-Mercaptopurin (6-MP)